Modulation of the expression of the D,-dopamine receptor gene is involved in several pathological and developmental circumstances. The gene and the corresponding promoter regions of the rat D, receptor were isolated and partly characterized to study its regulation. The rat D,-receptor gene spans at least 50 kb, and possesses eight exons; its organization was compared to those of the other dopamine-receptor genes in a phylogenetic perspective. The gene contains two transcription-start sites: the major one is located about 320 bp upstream from the 3' end of the first exon, and a minor site is 70 bp further upstream. Transient-expression assays with fusion constructs comprising fragments of the D,-promoter region and the luciferase reporter gene confirmed the existence of two independent, TATA-lacking promoters. Both promoters separately induced transcription of the luciferase gene in C6 glioma, primary fibroblasts, GH3 and MMQ pituitary cell lines, among which only the MMQ cells normally express the D, receptor. Transcription is enhanced by the reunion of the two promoters, and modified by the addition of upstream sequences. Thus the 1-kb promoter region analysed does not contain all the elements necessary to confer tissue-specific expression of the gene, but does carry some positive and negative regulatory elements, which remain to be characterized.The D, dopaminergic receptor belongs to a membraneprotein superfamily which activates a very large range of cellular responses through a coupling to heterotrimeric guanine-nucleotide-binding regulatory proteins (G-proteins) [l-41. The dopamine-D2-receptor molecule has seven hydrophobic segments, which are presumed to cross the plasma membrane and are the hallmark of this protein family. The length of the third cytoplasmic loop is variable, at least in mammals [5-141, due'to alternative splicing of an exon. The D, receptor alone mediates the activity of dopamine in anterior and intermediary pituitary cells. In addition, it is involved in the important effects of dopamine in the central nervous system, mainly in the hypothalamus and the basal ganglia. In particular, it has been suggested that the sensorimotor impairment which defines Parkinsonian syndromes results from the lack of Dgeceptor activation, although the contribution of this [4, 151. In these pathological conditions, elicited either by receptor blockade or by a dysfunction of dopamine synthesis and release in the striatum, it has been shown that D, receptors are upregulated [16]. This could result in part from the increased synthesis of the receptor protein [17, 181. The expression of the D, receptor is modulated by chronic exposure to agonist in tumor cell lines, resulting either in up-regulation or down-regulation of the receptor function, depending on the cell type [19, 201. Among steroids, estrogen treatment has also been shown to increase the level of the D2 receptor in the striatum and pituitary gland, although the mechanism is unclear [21]. D, receptor synthesis is developmentally regulated both in...